Company registration number 11582920 (England and Wales)
Elite Clinical Management Ltd
Annual report and unaudited financial statements
For the year ended 31 December 2025
Elite Clinical Management Ltd
Company Information
Directors
Mrs H C Bryan
Mrs J Goodfellow
Company number
11582920
Registered office
c/o DJH Chester City
Military House
24 Castle Street
Chester
Cheshire
United Kingdom
CH1 2DS
Accountants
DJH Chester City Limited
C/o DJH Chester City
Military House
24 Castle Street
Chester
Cheshire
England
CH1 2DS
Elite Clinical Management Ltd
Contents
Page
Directors' report
1
Statement of financial position
2
Notes to the financial statements
3 - 6
Elite Clinical Management Ltd
Directors' Report
For the year ended 31 December 2025
- 1 -

The directors present their annual report and financial statements for the year ended 31 December 2025.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mrs H C Bryan
Mrs J Goodfellow
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mrs H C Bryan
Director
30 June 2026
Elite Clinical Management Ltd
Statement Of Financial Position
As at 31 December 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
785
1,442
Current assets
Stocks
9,889
-
Debtors
4
1,531
12,960
Cash at bank and in hand
20,901
36,197
32,321
49,157
Creditors: amounts falling due within one year
5
(31,706)
(47,103)
Net current assets
615
2,054
Net assets
1,400
3,496
Capital and reserves
Called up share capital
4
4
Profit and loss reserves
1,396
3,492
Total equity
1,400
3,496

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 30 June 2026 and are signed on its behalf by:
Mrs H C Bryan
Director
Company registration number 11582920 (England and Wales)
Elite Clinical Management Ltd
Notes to the financial statements
For the year ended 31 December 2025
- 3 -
1
Accounting policies
Company information

Elite Clinical Management Ltd is a private company limited by shares incorporated in England and Wales. The registered office is c/o DJH Chester City, Military House, 24 Castle Street, Chester, Cheshire, United Kingdom, CH1 2DS.

1.1
Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computers
33% on cost
Elite Clinical Management Ltd
Notes to the financial statements (continued)
For the year ended 31 December 2025
1
Accounting policies
(Continued)
- 4 -
1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.7
Retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

1.8

Work in progress

Work in progress is stated at estimated realisable value, after providing for non-recoverable amounts. Work in progess represents unbilled revenue.

Elite Clinical Management Ltd
Notes to the financial statements (continued)
For the year ended 31 December 2025
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
7
6
3
Tangible fixed assets
Computers
£
Cost
At 1 January 2025
2,573
Additions
291
At 31 December 2025
2,864
Depreciation and impairment
At 1 January 2025
1,131
Depreciation charged in the year
948
At 31 December 2025
2,079
Carrying amount
At 31 December 2025
785
At 31 December 2024
1,442
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,531
8,131
Other debtors
-
0
4,829
1,531
12,960
Elite Clinical Management Ltd
Notes to the financial statements (continued)
For the year ended 31 December 2025
- 6 -
5
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
12,969
12,519
Other taxation and social security
9,223
28,232
Other creditors
9,514
6,352
31,706
47,103
6
Related party transactions

During the year the Director's loaned to the company a total of £8,108 and were repaid a total of £7,759 in the year. The balance owing to the Directors as at 31.03.2026 is £1,404 (2025 - £1,055). The loans were unsecured, interest-free and repayable on demand.

2025-12-312025-01-01falsefalsefalse30 June 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMrs H C BryanMrs J Goodfellow115829202025-01-012025-12-3111582920bus:Director12025-01-012025-12-3111582920bus:Director22025-01-012025-12-3111582920bus:RegisteredOffice2025-01-012025-12-31115829202025-12-31115829202024-12-3111582920core:ComputerEquipment2025-12-3111582920core:ComputerEquipment2024-12-3111582920core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3111582920core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3111582920core:ShareCapital2025-12-3111582920core:ShareCapital2024-12-3111582920core:RetainedEarningsAccumulatedLosses2025-12-3111582920core:RetainedEarningsAccumulatedLosses2024-12-3111582920core:ComputerEquipment2025-01-012025-12-31115829202024-01-012024-12-3111582920core:ComputerEquipment2024-12-3111582920core:CurrentFinancialInstruments2025-12-3111582920core:CurrentFinancialInstruments2024-12-3111582920bus:PrivateLimitedCompanyLtd2025-01-012025-12-3111582920bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3111582920bus:FRS1022025-01-012025-12-3111582920bus:AuditExemptWithAccountantsReport2025-01-012025-12-3111582920bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP